wake up to a new era of home sleep testing

Scale your capacity, streamline your operations, and elevate your patients’ experience

Choose the services that achieve your practice goals — all with zero upfront costs.

SANSA Express

✓Huxley ships SANSA directly to your patient
✓Huxley provides setup and FAQ support 24/7/365
✓Your practice interprets the study and bills insurance

SANSA GO

✓Huxley supplies ready-to-test SANSA kits to your clinic
✓You dispense to the patient. No time wasted cleaning, downloading, handling batteries, or pairing with apps
✓Your practice interprets the study and bills insurance

SANSA 360

✓You refer the patient to a fully managed, in-network virtual pathway
✓Patient tests and reviews results with a board-certified sleep provider
✓Patient explores treatment options with help of the provider

Performance you can trust.
Straight from the chest.

With nine FDA-cleared physiologic channels, SANSA empowers you to diagnose with confidence and phenotype with precision. Distinguish central from obstructive sleep apnea, investigate positional and REM-related disease, and gain deeper insight into cardiovascular risk with ECG and hypoxic burden.

95%

Sensitivity for Sleep Apnea¹

99%

Accuracy for CSA²

±1

Mean AHI Difference¹

99%

Patient success³

Sleep apnea is a cardiovascular problem.

SANSA is the only home sleep apnea test that enables you to simultaneously evaluate sleep apnea, ECG, and hypoxic burden from a single wear.

Global burden of sleep apnea

1 in 4

adults have sleep apnea⁴

80%

undiagnosed⁴

cardiovascular mortality risk when untreated⁵

55%

less cardiovascular mortality when treated⁸

Untreated sleep apnea also carries 2× the risk of stroke^6,7, while treatment is associated with 30% less atrial fibrillation recurrence post-PVI⁹.

In a series of cardiology patients suspected of sleep apnea wearing SANSA¹⁰

70%

had sleep apnea (AHI ≥5)

had central sleep apnea (AHIc ≥10)

30%

had meaningful arrhythmias on ECG

Huxley HUB™

Save time and simplify workflows.

A cloud-native platform that puts the full patient journey at your fingertips.

✓FDA-cleared autoscoring at both 3% and 4% to improve consistency and efficiency
✓Real-time, epoch-by-epoch over-scoring
✓Clinically actionable and customizable report templates
✓Secure, HIPAA compliant data accessible anytime from any browser. No software to install
✓Seamless EHR integration available — order and report directly through your EHR

References

Goldstein C, et al. Polysomnography validation of SANSA to detect obstructive sleep apnea. Front Neurol. 2025. 3% desaturation.
Khayat R, et al. Detecting central sleep apnea using a multi-diagnostic chest-worn monitor. SLEEP. 2025.
Data on file. Huxley Medical, 2026.
Benjafield A, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019.
Young T, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. SLEEP. 2008.
Yaggi HK, et al. Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine. 2005.
Redline S, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010.
Benjafield A, et al. Positive airway pressure therapy and all-cause and cardiovascular mortality in people with obstructive sleep apnoea. Lancet Respir Med. 2025.
Fein AS, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. JACC. 2013.
Kenigsberg D, et al. Integrating Sleep Apnea and Arrhythmia Assessment in Cardiology Patients Using a Multi-Diagnostic Single-Patch Monitor. Atrial Fibrillation Symposium, 2026.